ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | -58.3% | 1,700 | -43.3% | 0.00% | -50.0% |
| Q1 2015 | $12,000 | -64.7% | 3,000 | -40.0% | 0.00% | -60.0% |
| Q4 2014 | $34,000 | -93.3% | 5,000 | -89.9% | 0.01% | -92.5% |
| Q2 2014 | $507,000 | +39.3% | 49,510 | +63.4% | 0.07% | +36.7% |
| Q1 2014 | $364,000 | +538.6% | 30,300 | +506.0% | 0.05% | +390.0% |
| Q4 2013 | $57,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |